BindingDB logo
myBDB logout

BDBM327943 N-(1-benzylpiperidin-4- yl)-5-(4-((5- methylisoxazol-3- yl)methyl)piperazine-1- carbonyl)picolinamide::US10377742, Compound 85::US9663496, Compound 85

SMILES: Cc1cc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(Cc3ccccc3)CC2)no1

InChI Key: InChIKey=GWJLUAVBJOJUAI-UHFFFAOYSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 327943   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5'-AMP-activated protein kinase catalytic subunit alpha-2


(Homo sapiens (Human))
BDBM327943
PNG
(N-(1-benzylpiperidin-4- yl)-5-(4-((5- methylisoxaz...)
Show SMILES Cc1cc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(Cc3ccccc3)CC2)no1
Show InChI InChI=1S/C28H34N6O3/c1-21-17-25(31-37-21)20-33-13-15-34(16-14-33)28(36)23-7-8-26(29-18-23)27(35)30-24-9-11-32(12-10-24)19-22-5-3-2-4-6-22/h2-8,17-18,24H,9-16,19-20H2,1H3,(H,30,35)
PDB

Reactome pathway

UniProtKB/SwissProt

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3.00E+3n/an/an/an/a



Rigel Pharmaceuticals, Inc.

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US10377742 (2019)


BindingDB Entry DOI: 10.7270/Q2RV0R22
More data for this
Ligand-Target Pair
ampk


(Homo sapiens (Human))
BDBM327943
PNG
(N-(1-benzylpiperidin-4- yl)-5-(4-((5- methylisoxaz...)
Show SMILES Cc1cc(CN2CCN(CC2)C(=O)c2ccc(nc2)C(=O)NC2CCN(Cc3ccccc3)CC2)no1
Show InChI InChI=1S/C28H34N6O3/c1-21-17-25(31-37-21)20-33-13-15-34(16-14-33)28(36)23-7-8-26(29-18-23)27(35)30-24-9-11-32(12-10-24)19-22-5-3-2-4-6-22/h2-8,17-18,24H,9-16,19-20H2,1H3,(H,30,35)
PDB

Reactome pathway

UniProtKB/SwissProt

antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 3.00E+3n/an/an/an/a



Rigel Pharmaceuticals, Inc

US Patent


Assay Description
Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti...


US Patent US9663496 (2017)


BindingDB Entry DOI: 10.7270/Q26975P8
More data for this
Ligand-Target Pair